首页|小剂量艾司氯胺酮复合瑞马唑仑用于老年患者椎管内麻醉全髋关节置换术临床观察

小剂量艾司氯胺酮复合瑞马唑仑用于老年患者椎管内麻醉全髋关节置换术临床观察

扫码查看
目的 观察小剂量艾司氯胺酮复合瑞马唑仑用于老年患者椎管内麻醉下全髋关节置换术的临床效果.方法 选择河南大学第一附属医院 2022 年 3-12 月择期行单侧全髋关节置换术的老年患者 72 例,根据随机数表法分为对照组(P组,n=36)和观察组(R组,n=36).P组采用艾司氯胺酮+丙泊酚,R组采用艾司氯胺酮+瑞马唑仑.选择腰 3-4(L3-4)间隙行腰-硬联合麻醉,维持平面胸 8(T8)以下.切皮前:P组静脉注射丙泊酚 0.5 mg/kg,后维持 1.0~1.5 mg/(kg·h),静脉泵注艾司氯胺酮 0.05~0.1 mg/(kg·h).R组静脉注射瑞马唑仑 0.05 mg/kg,后维持 0.1~0.2 mg/(kg·h),静脉泵注艾司氯胺酮 0.05~0.1 mg/(kg·h).记录入室时(T0)、麻醉平面固定后(T1)、静脉滴注瑞马唑仑或丙泊酚5(T2)、15(T3)、30(T4)、60(T5)min的心率(HR)、有创动脉压(IBP)、血氧饱和度(SPO2)和脑电双频指数(BIS)值.记录术中血管活性药物使用情况、停止泵药后苏醒时间及术后不良反应的发生情况.结果 T2~T5 两组BIS比较,差异无统计学意义(P>0.05),R组SPO2 较P组维持在偏高水平,差异有统计学意义(P<0.05),两组HR、平均动脉压(MAP)维持在正常范围,但R组较P组维持在偏高水平,差异有统计学意义(P<0.05).R组术中麻黄碱、阿托品使用率明显低于P组,差异有统计学意义(P<0.05).停止泵注药物后R组患者苏醒时间明显短于P组,差异有统计学意义(P<0.05),两组术后不良反应总发生率比较,差异无统计学意义(P>0.05).结论 小剂量艾司氯胺酮可复合瑞马唑仑用于老年患者椎管内麻醉下全髋关节置换术镇静,对呼吸、血流动力学影响小,术后苏醒快,不良反应发生率低.
Clinical observation of low-dose esketamine combined with remimazolam for intrathecal anesthesia in elderly patients undergoing total hip replacement
Objective To observe the clinical efficacy of low-dose esketamine combined with remimazolam for intrathecal anesthesia in elderly patients undergoing total hip replacement.Methods A total of 72 elderly patients were selected to receive the unilateral total hip replacement at the First Affiliated Hospital of Henan University from March to December 2022.The patients were divided into a control group(Group P,n=36)and an observation group(Group R,n=36)using a random number table method.Group P was injected with esketamine and propofol,while Group R was injected with esketamine and remimazolam.Combined spinal-epidural anesthesia was conducted at the lumbar3-4(L3-4)interspace,and the maintenance plane was below thoracic8(T8).Before skin incision:Group P received intravenous injection of 0.5 mg/kg propofol,maintained at 1.0-1.5 mg/(kg·h)afterward,and intravenous infusion of 0.05-0.1 mg/(kg·h)esketamine.Group R received intravenous injection of 0.05 mg/kg remimazolam,maintained at 0.1-0.2 mg/(kg·h)afterward,and intravenous infusion of 0.05-0.1 mg/(kg·h)esketamine.Heart rate(HR),invasive blood pressure(IBP),blood oxygen saturation(SPO2),and electroencephalographic bispectral index(BIS)values were recorded at the time of entry(T0),after anesthesia plane block(T1),and at 5(T2),15(T3),30(T4),and 60(T5)min of intravenous infusion of remimazolam or propofol.Intraoperative vasoactive drug administration,time to awakening after stopping pumping medication,and the occurrence of postoperative adverse reactions were recorded.Results At T2-T5 time point,there was no significant difference in BIS between the two groups(P>0.05),and SPO2 was maintained at a high level in Group R compared with Group P,with statistically significant difference(P<0.05).HR and mean arterial pressure(MAP)were maintained in the normal range in the two groups,but at a higher level in Group R compared with Group P,with statistically significant difference(P<0.05).intraoperative ephedrine and atropine utilization rates were significantly lower in Group R than in Group P,with statistically significant differences(P<0.05).the awakening time of patients in Group R was significantly shorter than that in Group P after stopping pumping medication,with statistically significant difference(P<0.05).and there was no statistically significant difference in the incidence of postoperative adverse reactions between the two groups(P>0.05).Conclusion Low-dose esketamine can be combined with remimazolam for sedation in elderly patients receiving total hip replacement under intrathecal anesthesia.It has minimal respiratory and hemodynamic effects,fast postoperative recovery,and a low incidence of adverse reactions.

EsketamineRemimazolamElderly patientsIntrathecal anesthesiaSedation

宋满、李凤娟、付春艳、刘静、韩箫笛、郑孝振

展开 >

河南大学第一附属医院麻醉与围术期医学科,河南开封 475000

艾司氯胺酮 瑞马唑仑 老年患者 椎管内麻醉 镇静

河南省医学科技攻关计划联合共建项目

LHGJ20220656

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(7)
  • 25